CONFIDENTIALMulti-Product License Agreement • April 1st, 2019 • NGM Biopharmaceuticals Inc • Pharmaceutical preparations • New York
Contract Type FiledApril 1st, 2019 Company Industry Jurisdiction[*] = Certain confidential information contained in this document, marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 406 of the Securities Act of 1933, as amended.
CONFIDENTIALMulti-Product License Agreement • March 25th, 2019 • NGM Biopharmaceuticals Inc • Pharmaceutical preparations • New York
Contract Type FiledMarch 25th, 2019 Company Industry Jurisdiction[*] = Certain confidential information contained in this document, marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 406 of the Securities Act of 1933, as amended.
CONFIDENTIALMulti-Product License Agreement • September 28th, 2018 • NGM Biopharmaceuticals Inc • Pharmaceutical preparations • New York
Contract Type FiledSeptember 28th, 2018 Company Industry Jurisdiction[*] = Certain confidential information contained in this document, marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 406 of the Securities Act of 1933, as amended.